JONA HATTANGADI-GLUTH, MD
ASSOCIATE PROFESSOR AND ASSISTANT VICE-CHAIR
BS Biology, Economics | Duke University 2001
MD | Harvard 2007
Residency | Harvard 2012
Clinical Focus | Central Nervous System Tumors, Stereotactic Radiosurgery, Breast Cancer, Proton Therapy
Dr. Hattangadi-Gluth is an Associate Professor and Assistant Vice-Chair of Faculty Climate and Development. She is the Central Nervous System (CNS) Tumor Section Chief and Director of the CNS Tumor Program at the California Proton Center. She is the Associate Director for Imaging Research in the Center for Precision Radiation Medicine (CPRM) within the Altman Clinical & Translational Research Institute (ACTRI) and Co-Lead of the CNS Disease Team at the UC San Diego Moores Cancer Center. In addition, she is also an active member of the RMAS Breast Cancer Disease Team.
A nationally-recognized expert in the treatment of patients with brain tumors, she serves on the National Comprehensive Cancer Network (NCCN) panel for the treatment of CNS malignancies and is the Chair of the CNS Tumor Track of the American Society of Radiation Oncology (ASTRO) Education Committee. Since 2014, Dr. Hattangadi-Gluth has been a member of the Board of Directors of the San Diego Brain Tumor Foundation and has been repeatedly recognized as a Top Doctor by the San Diego Magazine.
Her research focuses on the use of advanced magnetic imaging (MRI) techniques in radiation therapy planning and measuring response to radiation in brain tissue. A recipient of a prestigious NIH R-01 Grant evaluating image-guided cognitive-sparing radiosurgery, she is the principal investigator on several investigator-initiated clinical trials, including a longitudinal study of advanced diffusion imaging and serial neurocognitive testing to measure radiation-induced injury in brain tumor patients. In addition to her imaging research, she is also active in Health Outcomes research and has published studies on a wide range of topics including medical device recalls, industry payments to physicians and medical malpractice claims, which have appeared in many prestigious journals including the Journal of the American Medical Association (JAMA).
Show additional content areas below